{"RecieveEnt":"劲方医药科技（上海）有限公司","PayEnt":"弘晖资本/国药资本/石药集团/泰福资本/圣成投资","Money":"RMB1.2亿","Rounds":"A轮","Url":"https://zdb.pedaily.cn/inv/show19682/","Sn":"19682","Title":"汇桥弘甲基金、国药中生（上海）生物股权投资基金、圣成投资等投资劲方药业","Date":"2018年10月22日","Industry":"生物技术/医疗健康 > 医药"}